Sign Up Today and Learn More About Caresyntax Stock
Invest in or calculate the value of your shares in Caresyntax or other pre-IPO companies through EquityZen's platform.
Caresyntax Stock (CARS)
Caresyntax is a vendor neutral data-driven surgery platform that makes surgery smarter by reducing variability and improving efficency.
About Caresyntax Stock
Founded
2013
Headquarters
Boston, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR. Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients.
Caresyntax Press Mentions
Stay in the know about the latest news on Caresyntax
How IoT is transforming remote patient monitoring
healthcareitnews • Nov 04, 2024
Caresyntax Rakes In $180M To Make Hospital ORs More Efficient
medcitynews • Aug 19, 2024
ProAssurance backs Caresyntax
coverager • Aug 19, 2024
Caresyntax raises $180M for AI surgery, $40M fund for early-stage crypto projects, and Romania's booming tech ecosystem
tech • Aug 17, 2024
The Week’s 10 Biggest Funding Rounds: Cybersecurity Leads With Kiteworks’ Nearly Half-Billion-Dollar Deal
news • Aug 16, 2024
Investors in Caresyntax
Discover investors in Caresyntax stock and explore their portfolio companies
Caresyntax Management
Leadership team at Caresyntax
Co-Founder and CEO
Dennis Kogan
Chief Financial Officer
Claire Masterson
Join now and verify your accreditation status to gain access to:
- Caresyntax current valuation
- Caresyntax stock price
- Available deals in Caresyntax and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Caresyntax stock?
Accredited investors can buy pre-IPO stock in companies like Caresyntax through EquityZen funds. These investments are made available by existing Caresyntax shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Caresyntax stock?
Shareholders can sell their Caresyntax stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
